thoughts on Lilly's results......I like the PMN tech , and am very hopeful it succeeds; but I am thinking Lilly would be smart enough to pick soluable AB prion types that have a high correlation with AD and as such their recent failure in their high powered study, to me is a negative for PMN ---- just picking numbers out of the air partly but on the AB side maybe 50% of the potential with PMN may be lost .... however the 5 prions targeted by pmn may be totally different than what Lilly targeted so PMN still has a chance... but just considering the power and money spent by Lilly might lead you to think they would have picked the target soluable prion(s) carefully...I think PMN will address the Lilly results more after Lilly come out with more detail in early 2017....
On the Tau Tangle side...which they are not yet recearching in the current 100 patient study, I think the potential is unchanged, and their science looks stromg to me, ....but I am not sure when they will do a similar study on Tau....